Last 12 months
Inside the activity.
2 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 2 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
BUTEL JEAN LUCDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,875 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 3 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 18,875 shares Expires 2031-07-28 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/3rd of the shares subject to the option vested on April 20, 2022; and 1/36th of the shares subject to the option vested monthly over the following two years. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
BUTEL JEAN LUCDirector
|
GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
BUTEL JEAN LUCDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (Right to Buy) · Derivative | 15,423 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 4 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,317 Underlying: Class A Common Stock · 15,423 shares Expires 2031-07-28 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Ausiello Dennis ADirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 15,423 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 3 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,423 shares Expires 2031-07-28 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 2 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Ausiello Dennis ADirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 17:00 UTC |
Nanavaty MaulikDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,423 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 4 Nanavaty Maulik · CIK 0001529708 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,317 Underlying: Class A Common Stock · 15,423 shares Expires 2031-07-28 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 17:00 UTC |
Nanavaty MaulikDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 15,423 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 3 Nanavaty Maulik · CIK 0001529708 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,423 shares Expires 2031-07-28 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 17:00 UTC |
Nanavaty MaulikDirector
|
GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 2 Nanavaty Maulik · CIK 0001529708 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 17:00 UTC |
Nanavaty MaulikDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 1 Nanavaty Maulik · CIK 0001529708 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Rometty Lisa AnnDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,708 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 4 Rometty Lisa Ann · CIK 0001902958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,037 Underlying: Class A Common Stock · 17,708 shares Expires 2032-01-02 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Rometty Lisa AnnDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 17,708 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 3 Rometty Lisa Ann · CIK 0001902958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,708 shares Expires 2032-01-02 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Rometty Lisa AnnDirector
|
GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 2 Rometty Lisa Ann · CIK 0001902958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Rometty Lisa AnnDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 1 Rometty Lisa Ann · CIK 0001902958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 23:00 UTC |
McKinley KateChief Business Officer
|
PurchaseClass A Common Stock | 17,960 | $1.67 | $29,993.20 |
DisclosureSEC source: 0000950170-24-136787 · ownership.xml · nonDerivative · entry 1 McKinley Kate · CIK 0001979211 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,960 Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 18:12 UTC |
Imran TalatDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 10,296 | $1.94 | $19,974.24 |
DisclosureSEC source: 0000950170-24-134828 · ownership.xml · nonDerivative · entry 1 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,751 F1 · balance_after: Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:30 UTC |
South Lake One LLC10% owner
|
SaleClass A Common Stock | 523,738 | $3.26 | $1,705,395.68 |
DisclosureSEC source: 0001104659-24-109543 · tm2426414-2_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 8,302,194 F3 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:30 UTC |
South Lake One LLC10% owner
|
SaleClass A Common Stock | 3,305,622 | $2.55 | $8,436,277.91 |
DisclosureSEC source: 0001104659-24-109543 · tm2426414-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 8,825,932 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:48 UTC |
IMRAN MIR ADirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066722 · ownership.xml · derivative · entry 1 IMRAN MIR A · CIK 0001031686 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| May 29, 2024 Filed May 30, 2024 16:10 UTC |
DEBUONO LAUREENDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066580 · ownership.xml · derivative · entry 1 DEBUONO LAUREEN · CIK 0001034447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| May 29, 2024 Filed May 30, 2024 16:10 UTC |
Farquharson AndrewDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066582 · ownership.xml · derivative · entry 1 Farquharson Andrew · CIK 0001865699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:10 UTC |
BUTEL JEAN LUCDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066578 · ownership.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:10 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066586 · ownership.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| May 29, 2024 Filed May 30, 2024 16:10 UTC |
Nanavaty MaulikDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066581 · ownership.xml · derivative · entry 1 Nanavaty Maulik · CIK 0001529708 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:10 UTC |
Rometty Lisa AnnDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066579 · ownership.xml · derivative · entry 1 Rometty Lisa Ann · CIK 0001902958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:00 UTC |
Hashim MirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 323,500 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0000950170-24-035571 · ownership.xml · derivative · entry 1 Hashim Mir · CIK 0001875891 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,500 Underlying: Class A Common Stock · 323,500 shares Expires 2034-03-20 F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024. Read SEC document |
| March 21, 2024 Filed Mar 23, 2024 01:00 UTC |
Imran TalatDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,085,000 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0000950170-24-035573 · ownership.xml · derivative · entry 1 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,085,000 Underlying: Class A Common Stock · 1,085,000 shares Expires 2034-03-20 F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:00 UTC |
Sanford Svai SChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 323,500 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0000950170-24-035570 · ownership.xml · derivative · entry 1 Sanford Svai S · CIK 0001591411 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,500 Underlying: Class A Common Stock · 323,500 shares Expires 2034-03-20 F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024. Read SEC document |
| March 21, 2024 Filed Mar 23, 2024 01:25 UTC |
McKinley KateChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 323,500 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0000950170-24-035576 · ownership.xml · derivative · entry 1 McKinley Kate · CIK 0001979211 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,500 Underlying: Class A Common Stock · 323,500 shares Expires 2034-03-20 F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024. Read SEC document |
| March 21, 2024 Filed Mar 23, 2024 01:00 UTC |
Groen EricGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 323,500 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0000950170-24-035572 · ownership.xml · derivative · entry 1 Groen Eric · CIK 0001918630 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,500 Underlying: Class A Common Stock · 323,500 shares Expires 2034-03-20 F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
IMRAN MIR ADirector
|
GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071465 · ownership.xml · derivative · entry 2 IMRAN MIR A · CIK 0001031686 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
IMRAN MIR ADirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-23-071465 · ownership.xml · derivative · entry 1 IMRAN MIR A · CIK 0001031686 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
DEBUONO LAUREENDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,875 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 4 DEBUONO LAUREEN · CIK 0001034447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,875 Underlying: Class A Common Stock · 18,875 shares Expires 2031-07-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
DEBUONO LAUREENDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,875 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 3 DEBUONO LAUREEN · CIK 0001034447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,021 Underlying: Class A Common Stock · 18,875 shares Expires 2031-07-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F3 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years. F3 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
DEBUONO LAUREENDirector
|
GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 2 DEBUONO LAUREEN · CIK 0001034447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
DEBUONO LAUREENDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 1 DEBUONO LAUREEN · CIK 0001034447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
Hashim MirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 83,724 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 6 Hashim Mir · CIK 0001875891 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,724 Underlying: Class A Common Stock · 83,724 shares Expires 2031-07-28 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F5 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
Hashim MirChief Scientific Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 83,724 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 5 Hashim Mir · CIK 0001875891 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,788 Underlying: Class A Common Stock · 83,724 shares Expires 2031-07-28 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F5 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
Hashim MirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 73,150 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 4 Hashim Mir · CIK 0001875891 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,150 Underlying: Class A Common Stock · 73,150 shares Expires 2032-03-21 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
Hashim MirChief Scientific Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 73,150 | Not disclosed Strike: $13.21 | Not disclosed |
DisclosureSEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 3 Hashim Mir · CIK 0001875891 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,250 Underlying: Class A Common Stock · 73,150 shares Expires 2032-03-21 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022. F2 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
Hashim MirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 171,500 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 2 Hashim Mir · CIK 0001875891 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,500 Underlying: Class A Common Stock · 171,500 shares Expires 2033-03-26 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 16:05 UTC |
Hashim MirChief Scientific Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 171,500 | Not disclosed Strike: $5.44 | Not disclosed |
DisclosureSEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 1 Hashim Mir · CIK 0001875891 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,300 Underlying: Class A Common Stock · 171,500 shares Expires 2033-03-26 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023. F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F2 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
Imran TalatDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 31,252 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 8 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,252 Underlying: Class A Common Stock · 31,252 shares Expires 2031-07-28 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F6 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
Imran TalatDirector · Chief Executive Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 31,252 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 7 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,699 Underlying: Class A Common Stock · 31,252 shares Expires 2031-07-28 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F6 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
Imran TalatDirector · Chief Executive Officer
|
Grant271875 · Derivative | 271,875 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 6 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,875 Underlying: Class A Common Stock · 271,875 shares Expires 2031-09-08 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F5 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
Imran TalatDirector · Chief Executive Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 271,875 | Not disclosed Strike: $19.56 | Not disclosed |
DisclosureSEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 5 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,125 Underlying: Class A Common Stock · 271,875 shares Expires 2031-09-08 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F5 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
Imran TalatDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 153,650 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 4 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,650 Underlying: Class A Common Stock · 153,650 shares Expires 2032-03-21 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
Imran TalatDirector · Chief Executive Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 153,650 | Not disclosed Strike: $13.21 | Not disclosed |
DisclosureSEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 3 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,750 Underlying: Class A Common Stock · 153,650 shares Expires 2032-03-21 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022. F2 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC |
Imran TalatDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 479,667 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 2 Imran Talat · CIK 0001869579 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,667 Underlying: Class A Common Stock · 479,667 shares Expires 2033-03-26 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.